CompletedPhase 4

Clinical Evaluation of Furocyst in Patients With Poly Cystic Ovary Syndrome

50 participantsStarted 2013-09

Plain-language summary

Poly cystic ovary syndrome (PCOS) is a disease which is prevalent in women of reproductive age facing obesity along with increased risk of type-2 diabetes and high cholesterol levels. The genetically determined cause of the PCOS includes disturbed levels of insulin and androgens. Standardized fenugreek seed extract (Furocyst) contains compounds such as saponins \& flavonoids which act on the insulin and indirectly helps to regulate the androgen levels in the body.

Who can participate

Age range

18 Years – 45 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Premenopausal women between 18-45 years of age and BMI less than 42 * Diagnosed with PCOS * Adequate hepatic, renal and hematological functions * Patients willing to give informed consent in writing Exclusion Criteria: * Males * Post menopausal women * Women with hysterectomy * Patients with congenital adrenal hyperplasia * Patients suffering from Cushing's syndrome * Patients diagnosed with androgen secreting tumors * Patients with thyroid dysfunction (T3, T4 level is higher than that in normal women of reproductive age) * Patients with Hypo-gonadotropic and Hypo-gonadism (central origin of ovarian dysfunction) * Pregnancy or desire for pregnancy or lactating mothers

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Reduction in Ovary volume as assessed by ultrasound

Timeframe: 12 weeks

Trial details

NCT IDNCT02789488

SponsorChemical Resources

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2014-07

View on ClinicalTrials.gov More Poly Cystic Ovary Syndrome trials